478 related articles for article (PubMed ID: 17991862)
1. Bypass of DNA lesions generated during anticancer treatment with cisplatin by DNA polymerase eta.
Alt A; Lammens K; Chiocchini C; Lammens A; Pieck JC; Kuch D; Hopfner KP; Carell T
Science; 2007 Nov; 318(5852):967-70. PubMed ID: 17991862
[TBL] [Abstract][Full Text] [Related]
2. Polymerization by DNA polymerase eta is blocked by cis-diamminedichloroplatinum(II) 1,3-d(GpTpG) cross-link: implications for cytotoxic effects in nucleotide excision repair-negative tumor cells.
Chijiwa S; Masutani C; Hanaoka F; Iwai S; Kuraoka I
Carcinogenesis; 2010 Mar; 31(3):388-93. PubMed ID: 20015866
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of extension of mismatched primer termini across from cisplatin and oxaliplatin adducts by human DNA polymerases beta and eta in vitro.
Bassett E; Vaisman A; Havener JM; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2003 Dec; 42(48):14197-206. PubMed ID: 14640687
[TBL] [Abstract][Full Text] [Related]
4. Replication of a cis-syn thymine dimer at atomic resolution.
Ling H; Boudsocq F; Plosky BS; Woodgate R; Yang W
Nature; 2003 Aug; 424(6952):1083-7. PubMed ID: 12904819
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for cisplatin DNA damage tolerance by human polymerase η during cancer chemotherapy.
Ummat A; Rechkoblit O; Jain R; Roy Choudhury J; Johnson RE; Silverstein TD; Buku A; Lone S; Prakash L; Prakash S; Aggarwal AK
Nat Struct Mol Biol; 2012 May; 19(6):628-32. PubMed ID: 22562137
[TBL] [Abstract][Full Text] [Related]
6. Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity.
McCulloch SD; Kokoska RJ; Masutani C; Iwai S; Hanaoka F; Kunkel TA
Nature; 2004 Mar; 428(6978):97-100. PubMed ID: 14999287
[TBL] [Abstract][Full Text] [Related]
7. Human DNA polymerase kappa encircles DNA: implications for mismatch extension and lesion bypass.
Lone S; Townson SA; Uljon SN; Johnson RE; Brahma A; Nair DT; Prakash S; Prakash L; Aggarwal AK
Mol Cell; 2007 Feb; 25(4):601-14. PubMed ID: 17317631
[TBL] [Abstract][Full Text] [Related]
8. Recognition and processing of cisplatin- and oxaliplatin-DNA adducts.
Chaney SG; Campbell SL; Bassett E; Wu Y
Crit Rev Oncol Hematol; 2005 Jan; 53(1):3-11. PubMed ID: 15607931
[TBL] [Abstract][Full Text] [Related]
9. Structural Basis for Human DNA Polymerase Kappa to Bypass Cisplatin Intrastrand Cross-Link (Pt-GG) Lesion as an Efficient and Accurate Extender.
Jha V; Ling H
J Mol Biol; 2018 May; 430(11):1577-1589. PubMed ID: 29715472
[TBL] [Abstract][Full Text] [Related]
10. Single d(GpG)/cis-diammineplatinum(II) adduct-induced inhibition of DNA polymerization.
Suo Z; Lippard SJ; Johnson KA
Biochemistry; 1999 Jan; 38(2):715-26. PubMed ID: 9888812
[TBL] [Abstract][Full Text] [Related]
11. The role of DNA polymerase eta in UV mutational spectra.
Choi JH; Pfeifer GP
DNA Repair (Amst); 2005 Feb; 4(2):211-20. PubMed ID: 15590329
[TBL] [Abstract][Full Text] [Related]
12. Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts.
Vaisman A; Lim SE; Patrick SM; Copeland WC; Hinkle DC; Turchi JJ; Chaney SG
Biochemistry; 1999 Aug; 38(34):11026-39. PubMed ID: 10460158
[TBL] [Abstract][Full Text] [Related]
13. Evidence for Watson-Crick and not Hoogsteen or wobble base pairing in the selection of nucleotides for insertion opposite pyrimidines and a thymine dimer by yeast DNA pol eta.
Hwang H; Taylor JS
Biochemistry; 2005 Mar; 44(12):4850-60. PubMed ID: 15779911
[TBL] [Abstract][Full Text] [Related]
14. Protein-template-directed synthesis across an acrolein-derived DNA adduct by yeast Rev1 DNA polymerase.
Nair DT; Johnson RE; Prakash L; Prakash S; Aggarwal AK
Structure; 2008 Feb; 16(2):239-45. PubMed ID: 18275815
[TBL] [Abstract][Full Text] [Related]
15. Adduct size limits efficient and error-free bypass across bulky N2-guanine DNA lesions by human DNA polymerase eta.
Choi JY; Guengerich FP
J Mol Biol; 2005 Sep; 352(1):72-90. PubMed ID: 16061253
[TBL] [Abstract][Full Text] [Related]
16. Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta.
Vaisman A; Masutani C; Hanaoka F; Chaney SG
Biochemistry; 2000 Apr; 39(16):4575-80. PubMed ID: 10769112
[TBL] [Abstract][Full Text] [Related]
17. The N2-ethylguanine and the O6-ethyl- and O6-methylguanine lesions in DNA: contrasting responses from the "bypass" DNA polymerase eta and the replicative DNA polymerase alpha.
Perrino FW; Blans P; Harvey S; Gelhaus SL; McGrath C; Akman SA; Jenkins GS; LaCourse WR; Fishbein JC
Chem Res Toxicol; 2003 Dec; 16(12):1616-23. PubMed ID: 14680376
[TBL] [Abstract][Full Text] [Related]
18. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
[TBL] [Abstract][Full Text] [Related]
19. The role of DNA polymerase eta in translesion synthesis past platinum-DNA adducts in human fibroblasts.
Bassett E; King NM; Bryant MF; Hector S; Pendyala L; Chaney SG; Cordeiro-Stone M
Cancer Res; 2004 Sep; 64(18):6469-75. PubMed ID: 15374956
[TBL] [Abstract][Full Text] [Related]
20. Structural basis for the bypass of the major oxaliplatin-DNA adducts by human DNA polymerase η.
Ouzon-Shubeita H; Baker M; Koag MC; Lee S
Biochem J; 2019 Feb; 476(4):747-758. PubMed ID: 30709915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
